Athenahealth Inc. Fourth Quarter Earnings Sneak Peek
athenahealth, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst estimate is for profit of 16 cents per share, a decline of 23.8% from the company’s actual earnings for the year-ago quarter. The average estimate is the same as three months ago. Between one and three months ago, the average estimate was unchanged. It also has not changed during the last month. Analysts are projecting profit to rise by 54.1% compared to last year’s 57 cents.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by one cent, reporting net income of 15 cents per share against a mean estimate of profit of 14 cents per share.
Investing Insights: Will the iPad 3 Be the Next Catalyst for Apple’s Stock?
Wall St. Revenue Expectations: Analysts are projecting a rise of 33.2% in revenue from the year-earlier quarter to $92.4 million.
Analyst Ratings: With nine analysts rate analysts rating the stock a buy, two rate rating it as a sell, and 11 rate rating it a hold, analysts are bullish on the stock.
A Look Back: In the third quarter, profit rose 38% to $5.3 million (15 cents a share) from $3.8 million (11 cents a share) the year earlier, exceeding analyst expectations. Revenue rose 32.6% to $83.7 million from $63.1 million.
The company has enjoyed double-digit year-over-year percentage revenue growth for the past four quarters. Over that span, the company has averaged growth of 32.5%, with the biggest boost coming in the fourth quarter of the last fiscal year when revenue rose 36% from the year earlier quarter.
The company has seen net income rise in three consecutive quarters. Net income rose more than threefold in the second quarter and 1073.6% in the first quarter.
Stock Price Performance: From January 11, 2012 to February 9, 2012, the stock price rose $9.72 (17.6%), from $55.10 to $64.82. The stock price saw one of its best stretches over the last year between January 31, 2012 and February 8, 2012, when shares rose for seven straight days, increasing 13.1% (+$7.61) over that span. It saw one of its worst periods between October 24, 2011 and November 1, 2011 when shares fell for seven straight days, dropping 11.9% (-$7.16) over that span.
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)
Don’t Miss These Additional Hot Stories:
To contact the reporter on this story: Derek Hoffman at firstname.lastname@example.org
To contact the editor responsible for this story: Damien Hoffman at email@example.com